Vee Excel Drugs And Pharmaceuticals Private Limited, a active private limited company, was established on 13 March 2000 in Delhi, Delhi, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24239DL2000PTC104382. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.82 M.
It upholds a compliant status. Employing 11 professional, Its leadership includes Vipin Bansal (Whole-Time Director), Anu Bansal (Director). It holds ₹22.79 Cr open charges and ₹21.10 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at G-16 Preet Viharvikash Marg, Delhi, Delhi, 110092.
U24239DL2000PTC104382
104382
13 March 2000
₹5.00 M
₹2.82 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Vee Excel Drugs And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vipin Bansal | Whole-Time Director | 14 Feb 2004 | Current |
| Anu Bansal | Director | 01 Sep 2001 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vee Excel Drugs And Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.73% increase. The company also saw a substantial improvement in profitability, with a 409.12% increase in profit. The company's net worth moved up by a moderate rise of 6.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Vee Excel Drugs And Pharmaceuticals had a public holding of 15.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹227,912,000.00
₹210,985,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2024 | Others | ₹4.56 Cr | Open |
| 30 Mar 2019 | Others | ₹18.23 Cr | Open |
| 16 Sep 2021 | Sidbi | ₹1.50 Cr | Satisfied |
| 02 Jun 2021 | Sidbi | ₹1.56 Cr | Satisfied |
| 14 Oct 2016 | Sidbi | ₹4.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Vee Excel Drugs And Pharmaceuticals has a workforce of 11 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vee Excel Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vee Excel Drugs And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vee Excel Drugs And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Vee Excel Drugs And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
A charge with Others amounted to Rs. 45.60 M with Charge ID 100851563 was registered on 20 Jan 2024. was recorded as a recent event.
Progress on A charge with Others of Rs. 182.31 M registered on 30 Mar 2019 with Charge ID 100274721 was modified on 09 Aug 2023. was documented.
Progress on A charge registered on 14 Oct 2016 via Charge ID 100055892 with Sidbi was fully satisfied on 04 May 2023. was documented.
Progress on A charge registered on 16 Sep 2021 via Charge ID 100477791 with Sidbi was fully satisfied on 17 Apr 2023. was documented.
The CIN of Vee Excel Drugs And Pharmaceuticals Private Limited is U24239DL2000PTC104382.
Vee Excel Drugs And Pharmaceuticals Private Limited is headquartered at G-16 Preet Viharvikash Marg, Delhi, Delhi, 110092.
Vee Excel Drugs And Pharmaceuticals Private Limited was incorporated on 13 March 2000.
The current directors of Vee Excel Drugs And Pharmaceuticals Private Limited are
The primary industry of Vee Excel Drugs And Pharmaceuticals Private Limited is Manufacturing.
Vee Excel Drugs And Pharmaceuticals Private Limited is unlisted.
The authorized capital of Vee Excel Drugs And Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹2.82 M.
The compliance status of Vee Excel Drugs And Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX